Research Finds Cannabis Effective for Migraines Aug. 2, 2022 Researchers in the Mel and Enid Zuckerman College of Public Health analyzed previously published scientific studies on the effects of cannabinoids on migraine patients. Cannabis Now
What's Your Pleasure? Time to Try a Sexual Wellness Retreat Aug. 2, 2022 Six Senses in Spain is hosting a retreat centered on women’s sexual wellness to be led by Nicola Finley, MD, an internal medicine physician and associate in the Health Promotion Sciences Department in the Mel and Enid Zuckerman College of Public Health. Travel + Leisure Southeast Asia
College Food Pantries Help Feed Students Aug. 2, 2022 Continuing coverage: Access to on-campus food pantries is making a difference for college students in California, according to a study. Farm Progress
Hepatitis B Vaccine at Birth: What's the Rush? Aug. 2, 2022 Sharon C. Hitchcock, DNP, RNC-MNN, assistant clinical professor in the College of Nursing, authored an essay about Hepatitis B vaccine safety. Healthy Mom & Baby
Understanding Infectious Diseases to Improve Health Aug. 1, 2022 Dr. Janko Nikolich-Žugich’s past experiences left him uniquely prepared to fight a global pandemic – and help prevent the next one. Read more Image
Following Nature's Rules, Researchers Develop New Methods for Treating Degenerative Neurological Disease Aug. 1, 2022 The University of Arizona has licensed the new class of drugs designed to penetrate the blood-brain barrier to startup Teleport Pharmaceuticals. Read more Image
Phoenix Office Construction Doubles in Q2 Aug. 1, 2022 Greater Phoenix’s office pipeline is expected to grow, with projects totaling some 10.5 million square feet planned. Commercial Property Executive
Oncology Tumor Panel Series: Part 5 – Ovarian Cancer Aug. 1, 2022 Research To Practice hosted a five-part case-based symposia series in conjunction with the Oncology Nursing Society's Annual Congress. Research To Practice | Oncology Videos
Do ICDs Still Work in Primary Prevention Given Today's HF Meds? July 29, 2022 Guidelines recommend patients with heart failure with reduced ejection fraction be on all four drug classes that together have shown improved survival in trials. Medscape